GT: The Podcast

0

Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.

Recent Episodes
  • Career Change: Making the Vision Come to Life • Private Practice Versus Academia
    May 23, 2025 – 15:16
  • Metabolic Dysfunction in Glaucoma
    Apr 28, 2025 – 29:11
  • Survey Says: Proceeding After Unsuccessful Treatment
    Mar 19, 2025 – 26:02
  • Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation
    Feb 24, 2025 – 07:58
  • Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye
    Jan 29, 2025 – 13:04
  • Survey Says: Treatment for a High-Risk Patient
    Dec 19, 2024 – 36:41
  • Chronic Stress and Glaucomatous Progression • Advances in Eye Drop Aids
    Nov 25, 2024 – 16:26
  • Improving the Affordability of Glaucoma Medications
    Oct 25, 2024 – 08:30
  • Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings
    Oct 16, 2024 – 18:03
  • Survey Says: Next Steps for Slowly Progressive Disease
    Sep 19, 2024 – 37:48
  • Masqueraders of Normal-Tension Glaucoma
    Aug 23, 2024 – 10:58
  • DARC: From Bench to Bedside
    Jul 22, 2024 – 23:13
  • Is Glaucoma Policy Short-Sighted?
    Jun 24, 2024 – 17:02
  • Back to Basics: Patient Encounters in Glaucoma
    Jun 5, 2024 – 22:58
  • Clinical Experiences With the Hydrus Microstent
    May 29, 2024 – 39:24
  • Survey Says: Fluctuating IOP and Poor Compliance
    May 28, 2024 – 39:37
  • Establishing a Glaucoma Practice Fresh Out of Fellowship
    Apr 22, 2024 – 09:18
  • Learning and Teaching MIGS
    Feb 23, 2024 – 08:18
  • Survey Says: Which Treatment Next?
    Jan 18, 2024 – 45:26
  • Clinical Experiences With the Hydrus Microstent
    Dec 28, 2023 – 43:27
  • Management of Tube Erosion
    Nov 29, 2023 – 11:25
  • Geographic Atrophy: A New Treatment Paradigm
    Nov 10, 2023 – 33:41
  • Patient Experience Data Collection
    Oct 24, 2023 – 08:16
  • Prioritizing Processes Over Goals
    Sep 25, 2023 – 08:41
  • Survey Says: Target IOP and Next Steps
    Aug 24, 2023 – 58:09
  • Suprachoroidal Hemorrhage
    Jul 25, 2023 – 08:03
  • Waste in Ophthalmology ORs
    Jun 26, 2023 – 14:33
  • Patients on Reddit
    May 23, 2023 – 08:35
  • Noninvasive Trabeculotomy Treatment for Glaucoma
    Apr 26, 2023 – 07:56
  • Remote Monitoring of Glaucoma
    Mar 22, 2023 – 15:02
  • Retinal Nerve Fiber Layer Optical Texture Analysis
    Feb 22, 2023 – 09:58
  • Teleophthalmology for Incidental Glaucoma Screening
    Jan 19, 2023 – 08:05
  • Survey Says: Procedure and IOL Selection
    Dec 14, 2022 – 44:08
  • Leading Through Uncertainty
    Nov 15, 2022 – 07:28
  • Physician Burnout in Ophthalmology
    Oct 14, 2022 – 09:14
  • Survey Says: Determining Target IOP and Next Steps
    Sep 13, 2022 – 40:09
  • Glaucoma Visionaries: Sean Ianchulev, MD, MPH
    Aug 17, 2022 – 12:17
  • Glaucoma Visionaries: Joel S. Schuman, MD, FACS
    Jul 15, 2022 – 10:22
  • ‘Survey Says’ With I. Paul Singh, MD
    Jun 15, 2022 – 41:18
  • Glaucoma Visionaries: Malik Y. Kahook, MD
    May 24, 2022 – 08:41
  • Remote Diagnostics for Closer Clinical Teamwork
    Apr 20, 2022 – 38:10
  • Introducing 'Survey Says' With I. Paul Singh, MD
    Mar 17, 2022 – 38:41
  • Lessons In Dissatisfaction • Not Your Grandma’s Puff Test
    Feb 16, 2022 – 11:47
  • A Holistic Approach to Glaucoma Care
    Jan 20, 2022 – 07:40
  • Reducing Pigment Particles in the Anterior Chamber
    Dec 20, 2021 – 09:24
  • Dose & Delivery: Defining Target IOP Ranges
    Dec 10, 2021 – 38:52
  • Is It Time to Rethink the Slit Lamp?
    Nov 18, 2021 – 09:21
  • The Contrast Sensitivity Story
    Oct 21, 2021 – 08:01
  • Dose & Delivery: New Mechanisms of Action
    Sep 22, 2021 – 30:38
  • The New Attending’s Perspective on MIGS
    Sep 22, 2021 – 14:04
Recent Reviews
  • midwestBlue
    10.29.24
    Excellent podcast! I am not a dr., I am a person with glaucoma. I just listened to the epi with Dr. Singh, a patient’s case and the survey on assorted social media. I am over in Madison, WI and I have not been impressed with the doctors that I have seen as they never look or treated me holistically since we don’t know why I have glaucoma. I have been reading about Dr. Singh and I would love to see him as he sounds like a dr. that likes to try to new and cutting edge things. Here is what my current dr. said: I asked him if he knew of any clinical trials I could apply to and without even discussing it he said NO. Then I asked him why do I have glaucoma and he actually said, guess you’re lucky. I need help. I wrote an email to the Kenosha eye center for Dr. Singh but never heard back. I am feeling quite alone and on my own in a city with no progressive glaucoma specialists.
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.